z-logo
Premium
Determination of ceftazidime in plasma by RP‐HPLC and ultraviolet detection
Author(s) -
Bergman Joan,
Harvill Lainey,
Hawkins Shawna,
Sladky Kurt,
Cox Sherry
Publication year - 2021
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.5104
Subject(s) - chromatography , chemistry , monobasic acid , high performance liquid chromatography , phosphoric acid , ceftazidime , absorbance , detection limit , acetonitrile , ultrafiltration (renal) , standard curve , organic chemistry , biology , bacteria , polymer chemistry , pseudomonas aeruginosa , genetics
A simple high‐performance liquid chromatography method for the determination of ceftazidime in plasma has been developed. Using an ultrafiltration technique samples were separated by reverse‐phase high‐performance liquid chromatography on a Symmetry C 18 4.6 × 250 mm column (5.0 μm) and ultraviolet absorbance was measured at 260 nm. The mobile phase was a mixture of 10 m m potassium phosphate monobasic pH 2.5 with phosphoric acid and acetonitrile (90:10). The standard curve ranged from 0.1 to 100 μg/ml. Intra‐ and inter‐assay variability for ceftazidime was <12%, and the average recovery was 89%. The lower limit of quantification was 0.1 μg/ml. This method has been used successfully to analyze frog plasma samples at this institution and it could be applied to other small volume samples in a clinical or research setting.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom